Find Rezvilutamide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1572045-62-5, Rezvilutamide [inn], Unii-70fjn2aw22, 70fjn2aw22, Ariane, Shr3680
Molecular Formula
C22H20F3N3O4S
Molecular Weight
479.5  g/mol
InChI Key
KRBMOYIWQCZVHA-INIZCTEOSA-N
FDA UNII
70FJN2AW22

Rezvilutamide
SHR3680 is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications.
1 2D Structure

Rezvilutamide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[3-[4-[(2S)-2,3-dihydroxypropoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
2.1.2 InChI
InChI=1S/C22H20F3N3O4S/c1-21(2)19(31)27(15-4-3-13(10-26)18(9-15)22(23,24)25)20(33)28(21)14-5-7-17(8-6-14)32-12-16(30)11-29/h3-9,16,29-30H,11-12H2,1-2H3/t16-/m0/s1
2.1.3 InChI Key
KRBMOYIWQCZVHA-INIZCTEOSA-N
2.2 Other Identifiers
2.2.1 UNII
70FJN2AW22
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1572045-62-5

2. Rezvilutamide [inn]

3. Unii-70fjn2aw22

4. 70fjn2aw22

5. Ariane

6. Shr3680

7. Rezvilutamide [who-dd]

8. 4-[3-[4-[(2s)-2,3-dihydroxypropoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

9. Shr-3680

10. 4-(3-(4-((s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile

11. Benzonitrile, 4-(3-(4-((2s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)-

12. Example 44 [wo2014036897a1]

13. Example 44 (wo2014036897a1)

14. 4-(3-(4-((2s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile

15. Refchem:179043

16. Shr 3680

17. Androgen Receptor Antagonist Shr3680

18. Rezvilutamida

19. Orb1691608

20. Chembl4650276

21. Schembl15506490

22. Schembl29509762

23. Gtpl12798

24. Dtxsid001336581

25. Glxc-26908

26. Akos040756903

27. (s)-4-(3-(4-(2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile

28. Da-57412

29. Ms-28910

30. Hy-137448

31. Cs-0138653

32. G18393

2.4 Create Date
2015-02-13
3 Chemical and Physical Properties
Molecular Weight 479.5 g/mol
Molecular Formula C22H20F3N3O4S
XLogP32.9
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count6
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area129
Heavy Atom Count33
Formal Charge0
Complexity791
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty